CEO, Vascular Strategies
Dr. Adelman is the CEO and co-Founder of Vascular Strategies LLC with over 30 years in the pharma discovery industry.
He is the former Sr. Director of Cardiovascular/Metabolic Diseases Research at Wyeth, advancing 10 compounds to clinical trials in cardiovascular, immune disorders and women’s health. Notably, he played a key role in developing the first drug-eluting stent (Cypher) in collaboration with Cordis/J&J which changed the paradigm for Interventional Cardiology.
His primary research interest includes the identification, implementation and management of research alliances and development collaborations, in-and out-licensing of technologies.